CHIMIRRI, Alba
 Distribuzione geografica
Continente #
NA - Nord America 16.133
EU - Europa 7.371
AS - Asia 6.335
SA - Sud America 2.569
AF - Africa 200
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 11
Totale 32.633
Nazione #
US - Stati Uniti d'America 15.915
SG - Singapore 2.655
BR - Brasile 2.280
IE - Irlanda 1.819
CN - Cina 1.571
SE - Svezia 1.566
UA - Ucraina 1.108
DE - Germania 763
VN - Vietnam 743
HK - Hong Kong 707
GB - Regno Unito 450
FI - Finlandia 429
RU - Federazione Russa 381
IT - Italia 380
IN - India 183
AR - Argentina 111
CA - Canada 101
FR - Francia 101
MX - Messico 71
PL - Polonia 66
BD - Bangladesh 63
CZ - Repubblica Ceca 60
TR - Turchia 56
IQ - Iraq 52
AT - Austria 50
EC - Ecuador 49
ZA - Sudafrica 46
MA - Marocco 45
BE - Belgio 42
JP - Giappone 39
UZ - Uzbekistan 37
NL - Olanda 34
CI - Costa d'Avorio 33
CO - Colombia 32
ES - Italia 31
IR - Iran 28
CL - Cile 19
ID - Indonesia 19
PY - Paraguay 19
UY - Uruguay 18
VE - Venezuela 18
PK - Pakistan 17
EG - Egitto 16
JO - Giordania 16
KE - Kenya 16
AE - Emirati Arabi Uniti 15
IL - Israele 15
NP - Nepal 15
PE - Perù 15
TN - Tunisia 14
KG - Kirghizistan 13
OM - Oman 12
KZ - Kazakistan 11
LV - Lettonia 10
AZ - Azerbaigian 9
CH - Svizzera 9
SA - Arabia Saudita 9
AL - Albania 8
DO - Repubblica Dominicana 8
DZ - Algeria 8
BO - Bolivia 7
CR - Costa Rica 7
HN - Honduras 7
LT - Lituania 7
NZ - Nuova Zelanda 7
A2 - ???statistics.table.value.countryCode.A2??? 6
BG - Bulgaria 6
GR - Grecia 6
KR - Corea 6
PA - Panama 6
AO - Angola 5
JM - Giamaica 5
LB - Libano 5
RS - Serbia 5
SN - Senegal 5
XK - ???statistics.table.value.countryCode.XK??? 5
AU - Australia 4
BY - Bielorussia 4
CY - Cipro 4
KW - Kuwait 4
LU - Lussemburgo 4
MD - Moldavia 4
NI - Nicaragua 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
BA - Bosnia-Erzegovina 3
EE - Estonia 3
EU - Europa 3
GA - Gabon 3
GE - Georgia 3
GT - Guatemala 3
HU - Ungheria 3
LK - Sri Lanka 3
NO - Norvegia 3
PH - Filippine 3
PS - Palestinian Territory 3
PT - Portogallo 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AM - Armenia 2
Totale 32.601
Città #
Dallas 5.679
Jacksonville 2.074
Dublin 1.815
Chandler 1.403
Singapore 1.294
Nyköping 1.010
Ashburn 981
Beijing 751
Hong Kong 707
Dong Ket 505
Cambridge 357
Princeton 354
Los Angeles 335
Dearborn 333
Medford 300
Des Moines 271
Boardman 233
The Dalles 200
Buffalo 166
Ann Arbor 150
São Paulo 141
Lancaster 130
Woodbridge 110
Wilmington 96
Ho Chi Minh City 93
Moscow 86
New York 81
Belo Horizonte 74
Jinan 73
Hyderabad 68
San Mateo 68
Nanjing 65
Tianjin 62
Pune 55
Munich 52
Messina 51
Hanoi 50
Warsaw 50
Redondo Beach 48
Shenyang 48
Brno 47
Brooklyn 47
Rio de Janeiro 47
Vienna 44
Houston 43
Council Bluffs 42
Brasília 41
Milan 41
Brussels 39
Haikou 39
Tashkent 35
Turku 34
Abidjan 33
Seattle 32
Hebei 31
Zhengzhou 31
Chicago 30
Montreal 30
Campinas 29
London 28
Baghdad 27
Curitiba 27
Phoenix 27
Stockholm 27
Tokyo 27
Denver 26
Ningbo 26
Catania 25
Johannesburg 25
Atlanta 24
Amsterdam 23
Frankfurt am Main 23
Goiânia 23
Lappeenranta 23
Santa Clara 23
Washington 23
Hangzhou 22
Ottawa 22
Saint Petersburg 22
Augusta 21
Porto Alegre 21
Taizhou 21
Fuzhou 20
Ardabil 19
Düsseldorf 19
Norwalk 19
Nuremberg 19
San Francisco 19
St Petersburg 19
Guarulhos 18
Helsinki 18
Manchester 18
Salvador 18
São José dos Campos 18
Dhaka 17
Guayaquil 17
Nanchang 17
Orem 17
Poplar 17
Quito 17
Totale 22.016
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 4.544
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 232
1-Aryl-1H,3H-thiazolo[3,4-a]benzimidazole derivatives 225
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 223
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 223
1,3-Thiazolidin-4-ones: potent and selective anti-HIV-1 agents 216
1-Aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide derivatives: synthesis and biological evaluation 214
1-fluoromethyl-1-methyl-1H,3H-thiazolo-[3,4-a]benzimidazole 206
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 164
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 153
AMPA receptor antagonists: Synthesis and pharmacological evaluation 152
5H-[1,2,4]OXADIAZOLO[5,4-D][1,5]BENZOTHIAZEPINES - SYNTHESIS AND STEREOCHEMISTRY 141
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors 140
Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice 138
3H-AZIRINO[1,2-D][1,4]BENZODIAZEPIN-4 (5H)-ONES - SYNTHESIS AND STEREOCHEMISTRY 136
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 136
4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. 135
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors. 132
2-Hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: Influence of the alkylation of position 4 130
3-[2-(1H-1,3-benzodiazol-2-yl)ethyl]1,3-oxazolidin-2-one 129
3D Pharmacophore model and synthesys of NMDA receptor subunit NR2B antagonists 127
Identification of Potent and Selective Human Carbonic Anhydrase VII (hCA VII) Inhibitors 126
Design and synthesis of acetylcholinesterase inhibitors 124
A new potential approach to block HIV-1 replication via protein–protein interaction and strand-transfer inhibition 124
A refined pharmacophore model and optimization of 1H-benzylindole HIV-1 integrase inhibitors 123
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 121
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 119
Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4 '-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists 119
Anti-HIV agents: design and discovery of new potent RT inhibitors 117
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 117
Nuovi Antagonisti Noncompetitivi del Recettore AMPA a struttura tetraidroisochinolinica, 116
Antiretroviral strategy using multi-target agents 115
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 114
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 113
3D Pharmacophore Models for 1,2,3,4-Tetrahydroisoquinoline Derivatives Acting as Anticonvulsant Agents 113
Anticonvulsant activity and plasma level of 2,3-benzodiazepin- 4-ones (CFMs) in genetically epilepsy-prone rats 111
7,11b-dihydro-9,10-dimethoxy-3,11b- diphenyl[1,2,4]oxadiazolo[5,4-a]-[2,3]benzodiazepin-6(5H)-one 111
Binding mode investigation and SAR studies of HIV-1 integrase inhibitors 111
Azirino[1,2-d][1,4]benzodiazepine derivatives and related 1,4- benzodiazepines as anticonvulsant agents in DBA/2 mice 111
Nuovi Antagonisti Non-Competitivi Del Recettore NMDA/NR2b: Design e Sintesi” 110
Modificazioni strutturali del gruppo dichetoacido (DKA) di potenti inibitori dell'Integrasi dell'HIV-1 110
Combined ligand-based and target-based approach to design NR2B/NMDA receptor antagonists 109
Identification of isoquinoline-sulfonamides as potent and selective carbonic anhydrase inhibitors 109
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 108
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants 108
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 106
Annelated 1,5-benzothiazepines 106
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL’INTEGRASI DELL’HIV-1 105
Discovery of potent and selective inhibitors of druggable carbonic anhydrase isoforms 105
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. 105
HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation 105
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies 104
Inhibitors of the Interactions between HIV-1 IN and the Cofactor LEDGF/p75 104
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking 103
Novel Potent Anticonvulsant Agent Containing a Tetrahydroisoquinoline Skeleton. 103
Sintesi e SAR di nuovi inibitori dell'acetilcolinesterasi come potenziali agenti anti-Alzheimer 103
Nuovi selettivi inibitori dell'anidrasi carbonica: sintesi, SAR e studi sull'interazione enzima/inibitore 102
From 3D-pharmacophore models to synthetic route towards anti-HIV agents 101
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 101
Binding modes of noncompetitive AMPA antagonists: a computational approach 100
Design e Sintesi di composti a struttura 3-Indol-Gliossilamidica come potenziali inibitori dell'integrasi dell'HIV-1. 100
Binding mode prediction of Strand Transfer HIV-1 Integrase Inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 Integrase 100
2-Acetil-1-(4'-clorofenil)-6,7-dimetossi-1,2,3,4-tetraidroisochinolina (Ps3Ac) Potente AMPA-antagonista: Definizione del Profilo Enantiofarmacobiologico 100
Optimization of a LC method for the enantio separation of a non-competitive glutamate receptor antagonist, by experimental design methodology 99
Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT-inhibitors. 98
New indole derivatives as promising ligands for ifenprodil site of NR2B/NMDA receptors 98
From NMDA receptor antagonists to discovery of selective σ2 receptor ligands 98
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 97
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 97
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 97
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 97
Derivati benzimidazolonici ed analoghi come potenti inibitori non-nucleosidici dell'RT dell'HIV-1 97
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 96
Synthesis, biological evaluation and docking studies of NR2B/NMDA receptor antagonists 96
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 95
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 95
Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation 95
An unexpected reaction between 2,3-dihydro-2,2,4-trimethyl-1H-1,5-benzodiazepine and mercaptoacetic acid 95
Structure-activity hypothesis in the design of new AMPA receptor antagonists. 94
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 94
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 94
PROGETTAZIONE E SINTESI DI NUOVI DERIVATI ISOCHINOLINICI COME AGENTI ANTICONVULSIVANTI MULTITARGET 94
Searching for NR2B/NMDA Receptor Antagonists As Neuroprotective Agents 94
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 93
Insight into the INSTIs binding mode: molecular modeling investigation and SAR studies 93
High-performance liquid chromatographic determination of new 2,3-benzodiazepines 92
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 92
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones 92
Computational Studies to Discover a New NR2B/NMDA Receptor Antagonist and Evaluation of Pharmacological Profile 92
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL'INTEGRASI DELL'HIV-1 92
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 92
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 92
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 91
Discovery of potent HIV-1 integrase strand transfer inhibitors: design and synthetic strategies 91
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 91
Synthesis, Structure-Activity Relationship Studies, and X-ray Crystallographic Analysis of Arylsulfonamides as Potent Carbonic Anhydrase Inhibitors. 91
Synthesis and pharmacological evaluation of 4-aryl-6,7- dimethoxyphthalazines as anticonvulsant agents 90
Synthesis and pharmacological evaluation of new tetrahydroisoquinoline derivatives. 89
HIV-1 integrase strand transfer inhibitors (INSTIs): design, synthesis and biological activity 89
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 89
Totale 15.979
Categoria #
all - tutte 112.660
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.660


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.733 0 0 0 0 0 310 8 277 5 276 235 622
2021/20221.911 22 339 48 59 108 9 132 76 37 25 367 689
2022/20235.684 471 420 263 419 502 616 118 341 2.258 17 217 42
2023/20241.285 109 219 85 224 120 208 24 64 2 109 34 87
2024/20255.986 103 96 163 373 243 208 56 1.443 1.579 283 460 979
2025/202610.262 595 2.455 4.338 1.326 1.357 191 0 0 0 0 0 0
Totale 32.813